Until around 10 years ago, the prognosis for people with multiple myeloma was poor. It’s still the second most common blood cancer after leukaemia – but thanks to better treatments, the situation is improving. Read more in this Nature Outlook that I edited.
biomedical research
Biomedical research is becoming more open about its funding and data
More journal articles are now including statements about conflicts of interest and data sharing. Biomedical research is shifting to become more open and transparent by providing increasing amounts of information about funding, conflicts of interest and data sharing in its publications, according to a survey of recent papers. Read more in Nature.
Nature Outlook: Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a devastating disease with poorly understood causes and no known cure. But research is slowly beginning to bring hope to those affected. This Outlook discusses topics such as: how genetic and epidemiological research are beginning to reveal the secrets of ALS; new drugs and other treatments that are finally becoming […]
Outlook: Multiple sclerosis
Multiple sclerosis is a devastating disease that induces the body’s own immune system to eat away at the central nervous system, slowly robbing patients of their physical mobility. It is also mysterious. Despite years of research, the cause remains elusive, and treatments are few and far between. But new research to find the causes and […]
Nature Outlook: Kidney cancer
Kidney cancer has long flown under the radar despite being one of the top-ten cancer killers worldwide. It lacks the research spotlight and public awareness of other cancers that can help to drive new discoveries. It remains hard to detect, difficult to treat and poorly understood. But that is starting to change as researchers dig […]
NIAID director wins Canada Gairdner Global Health Award
Infectious disease expert Anthony Fauci has been awarded 2016’s Global Health Award from the Gairdner Foundation for his decades of work against HIV/AIDS. Anthony Fauci, the director of the US National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID), has won the 2016 Global Health Award from Canada’s Gairdner Foundation for […]
Profile: The Scripps Research Institute under new leadership
Steve Kay, the new president of The Scripps Research Institute, has big plans for the venerable biomedical research institution. Alongside incoming CEO Peter Shultz, he hopes to extend the institute’s mission beyond basic science to incorporate more translational work, in a complete bench-to-bedside approach. “If you can couple the strength in basic sciences of an […]
2015 Nobel Prize goes to antiparasitic drug discoverers
This year’s Nobel Prize in Physiology or Medicine is awarded to three researchers from Japan, Ireland, and China who identified treatments for major tropical diseases. The discoverers of drugs to treat parasitic diseases that predominantly affect people in the developing world have won the 2015 Nobel Prize in Physiology or Medicine. Satoshi Omura, from Kitasato […]
George King: research leader at the Joslin Diabetes Center
Like many medical researchers, George King has a personal connection to the disease that he has spent his career studying. He has been working to understand and treat diabetes at the Joslin Diabetes Center in Boston, MA, USA, since 1981, partly because of how it has affected his own family. “Asians develop diabetes at a […]
Profile: Joslin Diabetes Center, Boston, MA, USA
The Joslin Diabetes Center has a long history of being on the cutting edge of diabetes care and research. It was founded 117 years ago by Elliott Joslin, a physician dedicated to understanding and treating type 1 diabetes in young people. He used the latest methods to treat the disease—which at that time mainly meant […]